These results explained the impaired but still significant tumor suppression ability of ATO in the immunodeficient Rag1−/− mice (Figure 4I), CD4+/CD8+ T cell depletion mice (Figure 4M), IFN-γ depletion mice (Figure 4P), and our previous studied mouse models.18 The gene discussed is CD8A; the disease is neoplasm.